H. Xie Erin's most recent trade in BlackRock Health Sciences Trust II was a trade of 23,649 Phantom Shares done . Disclosure was reported to the exchange on Jan. 31, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 23,649 | 23,649 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 14,882 | 14,882 | - | - | Common Stock | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Sale or transfer of securities back to the company at price $ 16.49 per share. | 31 Jan 2025 | 14,882 | 0 | - | 16.5 | 245,414 | Common Stock |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 13,471 | 13,471 (0%) | 0% | - | Common Stock | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Sale or transfer of securities back to the company at price $ 40.92 per share. | 31 Jan 2025 | 13,471 | 0 (0%) | 0% | 40.9 | 551,239 | Common Stock |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 9,530 | 9,530 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 7,835 | 15,671 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 7,046 | 7,046 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 6,109 | 0 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 4,587 | 4,587 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 2,773 | 5,547 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin Xie H. | Portfolio Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 18,023 | 18,023 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 14,946 | 14,946 (0%) | 0% | - | Common Stock | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Sale or transfer of securities back to the company at price $ 41.48 per share. | 31 Jan 2024 | 14,946 | 0 (0%) | 0% | 41.5 | 619,995 | Common Stock |
BlackRock Health Sciences ... | H. Xie Erin | Portfolio Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 7,790 | 7,790 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | H. Erin Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 6,369 | 12,738 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Xie Erin H. | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 6,369 | 6,369 | - | - | Common Stock | |
BlackRock Health Sciences ... | Xie Erin H. | Portfolio Manager | Sale or transfer of securities back to the company at price $ 17.93 per share. | 31 Jan 2024 | 6,369 | 0 | - | 17.9 | 114,203 | Common Stock |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 5,720 | 5,720 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | H. Erin Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 4,930 | 0 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Xie Erin H. | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 4,295 | 8,591 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 21,173 | 21,173 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Xie H. Erin | Portfolio Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 18,124 | 18,124 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Sale or transfer of securities back to the company at price $ 43.56 per share. | 31 Jan 2023 | 13,966 | 0 (0%) | 0% | 43.6 | 608,389 | Common Stock |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 13,966 | 13,966 (0%) | 0% | - | Common Stock | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 12,095 | 12,095 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 5,369 | 10,738 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 4,627 | 4,627 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 3,969 | 0 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Sale or transfer of securities back to the company at price $ 45.10 per share. | 31 Jan 2022 | 15,616 | 0 (0%) | 0% | 45.1 | 704,310 | Common Stock |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 15,616 | 15,616 (0%) | 0% | - | Common Stock | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 15,173 | 15,173 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 7,517 | 0 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 4,359 | 8,718 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 3,739 | 3,739 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Sale or transfer of securities back to the company at price $ 47.88 per share. | 29 Jan 2021 | 13,867 | 0 (0%) | 0% | 47.9 | 663,954 | Common Stock |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2021 | 13,867 | 13,867 (0%) | 0% | - | Common Stock | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 12,425 | 12,425 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2021 | 7,142 | 7,142 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2021 | 3,552 | 7,105 | - | - | Phantom Shares | |
BlackRock Health Sciences ... | Erin H. Xie | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2021 | 3,171 | 0 | - | - | Phantom Shares |